Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GSK diabetes drug set for European approval
Yahoo/Reuters
Friday, January 24, 2014 - 9:36am
tags:
GSK, diabetes, Europe, Eperzan, albiglutide, GLP-1 agonist
Intuitive Surgical Tops on Q4 Earnings & Revs
Yahoo/Zacks.com
Friday, January 24, 2014 - 9:35am
tags:
Intuitive Surgical, earnings, devices
With Iclusig back to market, would Eli Lilly bid for Ariad? Would anyone?
Fierce Pharma
Friday, January 24, 2014 - 9:12am
tags:
Iclusig, M&A, Ariad Pharmaceuticals, Eli Lilly
Merck's RNAi Trash is Alnylam's Treasure
Motley Fool
Friday, January 24, 2014 - 9:10am
tags:
Merck, RNAi, Alnylam, patents
Bayer Wins EU Panel Backing for Lung Drug After FDA Approval
Bloomberg
Friday, January 24, 2014 - 9:08am
tags:
Bayer, Europe, FDA, Adempas, pulmonary hypertension
Teva’s Laquinimod MS Pill Fails to Win EU Agency Backing
Bloomberg
Friday, January 24, 2014 - 9:05am
tags:
laquinimod, MS, Europe, Teva Pharmaceuticals, multiple sclerosis
Inovio - Sitting At The Pot Of Gold
Seeking Alpha
Friday, January 24, 2014 - 9:04am
tags:
Inovio, drug delivery
Bristol-Myers Beats Earnings Estimates on Drug Sales Gain
Bloomberg
Friday, January 24, 2014 - 9:03am
tags:
earnings, Bristol-Myers Squibb
Merck Gets Good News On New Heart Attack Therapy
Motley Fool
Thursday, January 23, 2014 - 5:58pm
tags:
Merck, Vorapaxar, heart attacks
Will Bristol-Myers (BMY) Beat Q4 Earnings?
Yahoo/Zacks.com
Thursday, January 23, 2014 - 5:56pm
tags:
Bristol-Myers Squibb, earnings
Allergan Slips on Restasis Challenge
Yahoo/Zacks.com
Thursday, January 23, 2014 - 5:54pm
tags:
Allergan, Restasis, dry eye disease, Actavis, generics
Amgen cholesterol drug meets goal of third late stage trial
Yahoo/Reuters
Thursday, January 23, 2014 - 5:53pm
tags:
Amgen, evolocumab, PCSK9 inhibitors
[video] Sanofi Has One of Top 5 Drug Pipelines, CEO Says
Bloomberg
Thursday, January 23, 2014 - 5:52pm
tags:
Sanofi, Pharma CEOs, Chris Viehbacher
Bristol-Myers' New Nivolumab Trial Sparks Worries
Investors.com
Thursday, January 23, 2014 - 5:50pm
tags:
Bristol-Myers Squibb, nivolumab, clinical trials, non-small cell lung cancer
Medtronic's SureScan Wins FDA Approval
Yahoo/Reuters
Thursday, January 23, 2014 - 5:47pm
tags:
SureScan, Medtronic, FDA, devices
FDA halts drug imports from Ranbaxy plant in India
Yahoo/AP
Thursday, January 23, 2014 - 5:42pm
tags:
FDA, Ranbaxy, India
Ariad Joins Rumor Mill: Hope May Trump Reality
Wall St 24/7
Thursday, January 23, 2014 - 11:06am
tags:
Ariad Pharmaceuticals, Eli Lilly, M&A
Plandaí Sits at the Head of the Medical Marijuana Class
Yahoo/Accesswire
Thursday, January 23, 2014 - 10:46am
tags:
marijuana, Plandai Biotechnology
There’s A Patent Cliff But AstraZeneca Has A Jetpack
Motley Fool
Thursday, January 23, 2014 - 10:43am
tags:
patents, patent cliff, AstraZeneca, Crestor, Symbicort
St. Jude To Acquire Heart Failure Startup CardioMEMS before Mid 2014
Medical Device and Diagnostic Industry
Thursday, January 23, 2014 - 10:00am
tags:
St. Jude Medical, M&A, CardioMEMS, diagnostics, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.